Role of NRF2 in Lung Cancer

Miriam Sánchez-Ortega1, Ana Clara Carrera1, Antonio Garrido1

  • 1Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Cantoblanco, E-28049 Madrid, Spain.

Cells
|August 27, 2021
PubMed

Insights

The NRF2-KEAP1 pathway protects cells from stress but can drive lung cancer progression and chemotherapy resistance. Targeting NRF2 offers potential therapeutic strategies for these tumors.

Area of Science:

  • Molecular Biology
  • Cellular Stress Response
  • Oncology

Background:

  • The NRF2 transcription factor regulates cellular defense against oxidative stress.
  • KEAP1 protein controls NRF2 stability, targeting it for degradation under normal conditions.
  • Initially viewed as anti-cancer, NRF2 now shows pro-tumoral roles in metastasis and chemoresistance.

Purpose of the Study:

  • To review the molecular mechanisms of the NRF2/KEAP1 pathway in physiology.
  • To summarize NRF2/KEAP1's role in lung cancer development and progression.
  • To discuss therapeutic strategies targeting NRF2 in lung cancer.

Main Methods:

  • Literature review of NRF2/KEAP1 signaling.
  • Analysis of NRF2 activation mechanisms in cancer.
  • Summary of therapeutic interventions targeting NRF2.

Main Results:

  • NRF2 activation is frequent in lung cancers, promoting malignant phenotypes.
  • The dual role of NRF2 (cytoprotective vs. pro-tumoral) creates controversy in cancer research.
  • NRF2 contributes to lung cancer metastasis and resistance to treatments.

Conclusions:

  • The NRF2/KEAP1 pathway has complex, context-dependent roles in lung cancer.
  • Understanding NRF2 activation is crucial for developing effective lung cancer therapies.
  • Targeting NRF2 represents a promising therapeutic avenue for lung cancer treatment.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K